AtaiBeckley

📍 New York, United States👥 99 employees💰 Last funded May 2021
Biotechnology Research🌐 ataibeckley.com
Website LinkedIn
AtaiBeckley is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting and convenient mental health treatments.
16
Total investors
8
Early stage
6
Mid stage
0
Late stage
—
Founded

Investors

16 investors
All
Early stage
Mid stage
Late stage
Angel investors· 1
Chris Heyer
Chris Heyer
GP @Marvelous Ventures & LP @Marvelous Scito| ex CIO, CDO @Hypoport SE & ex GP CVC
Angel Investor (pooled)
mid stage
7 investments
Jan 2021
Early stage· 7
Erman Turan
Erman Turan
Founding Managing Partner @3dots
Investor (Exit - IPO)
early stage
21 investments
Oct 2020
Clio Smurro
Clio Smurro
Principal, Business Development @ Google | Stanford MBA
early stage
Jul 2020
Fabian Hansen
Fabian Hansen
Founder & Investor
early stage
7 investments
Jan 2020
Tomy Lorsch
Tomy Lorsch
CEO at ComplexChaos, AI for stakeholder alignment
early stage
12 investments
Nov 2019
DB
Dina Burkitbayeva
Investor at ATAI Life Sciences AG
early stage
Nov 2019
ST
Sean Trigony
Investor
early stage
57 investments
Aug 2019
Daniel Gutenberg
Daniel Gutenberg
Soonicorn Farmer
early stage
58 investments
2018
Series B· 1
Tobias Buck
Tobias Buck
Co-Founder & CFO I Multi-Strategy Investor | ex Goldman Sachs Private Equity
Investor | Series B (IPO on NASDAQ: ATAI)
5 investments
2019
Mid stage· 5
Patrick Schneider-Sikorsky
Patrick Schneider-Sikorsky
NATO Innovation Fund (NIF)
mid stage
37 investments
May 2021
Tyler Henry
Tyler Henry
Co-Founder at STURDY. // Managing Partner at Range Media
mid stage
11 investments
Apr 2021
Alessandro Graf
Alessandro Graf
I Empower People 🚀
Investor - IPO
mid stage
Mar 2021
Rafael Tamames
Rafael Tamames
🤖 🤖 Entrepreneur and Martech evangelist, AI Top Voice. Lecturer 🚀 Founder of @Findasense 🔄 Leading the transformation of #CX globally at @TP Infinity.
Private Investor
mid stage
7 investments
Mar 2021
Marc Penkala
Marc Penkala
General Partner @ āltitude | SME Tech Investor
Investor | Pioneering mental health | Nasdaq IPO
mid stage
38 investments
Jan 2021
Growth / Late stage· 1
Georg Runge
Georg Runge
Founder & CEO Xydra Labs | Building Frontier Ai Solutions | Banking + Insurance + Health Tech + Gov Tech | Angel Investor | web3 since 2014 | Speaker | Node Operator | Instigator
Investor (Series D)
early stage
5 investments
2020
Show all 16 investors ↓
Investor geography6 countries
United States
6
United Kingdom
3
Germany
3
Switzerland
2
Turkey
1
Spain
1
Investor activity2018–2021 · investors recorded per year
20181201942020520216
Recent (last 2y)Earlier
Frequently asked questions
Who invested in AtaiBeckley?
AtaiBeckley has 16 investors on record on gritt.io, including 8 early-stage backers, 6 mid-stage.
When did AtaiBeckley last raise funding?
The most recent investment in AtaiBeckley recorded on gritt.io was in May 2021.
What industry is AtaiBeckley in?
AtaiBeckley operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AtaiBeckley based?
AtaiBeckley is headquartered in New York, United States.